NALOXONE HYDROCHLOR

The Defense Logistics Agency awarded THE MACLEAN GROUP LLC, a small business with Small Disadvantaged and Women-Owned Small Business certifications, a firm-fixed-price contract valued at $4,929.30 under solicitation SPE2DP26P1016 for the procurement of five packages of naloxone hydrochloride injection, each containing ten single-dose 10 mg/0.4 mL auto-injectors. The contract, issued on July 16, 2026, requires delivery to Fort Bragg, North Carolina, with a strict 15-day performance window ending July 31, 2026, and FOB Destination terms placing all transportation responsibility and cost on the contractor. The item is subject to stringent medical packaging and labeling mandates governed by Medical Marking Standard No. 1, which supersedes MIL-STD-129, and DLA Packaging Requirements for Procurement (RP001), requiring sealed unit containers, proper preservation methods for refrigerated or frozen storage, and specific data fields like QUP, PRES MTHD, and WRAP MAT. Each shipment must include internal DLA forms and DD Form 250 with explicit storage instructions and lot-based expiration or manufacture dates. Invoicing and payment are exclusively processed through the Wide Area Workflow system, with electronic submission mandated by DFARS clauses, and payment is routed to the Defense Finance and Accounting Service in Columbus, Ohio. The contractor must comply with multiple federal regulations, including safeguarding covered defense information under DFARS 252.204-7012, reporting employment data for veterans via VETS-4212, and demonstrating compliance with anti-trafficking requirements. All deliveries must adhere to traceable shipping methods, and drivers must be enrolled in RapidGate for base access. Inspection and acceptance occur at the destination by government representatives, with final certification contingent on full compliance with the contract’s technical, packaging, and documentation requirements, reflecting a Lowest Price Technically Acceptable award approach with no price variance permitted.